Molecular Geriatrics Corporation
Records under this name other than patents Molecular Geriatrics Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to Molecular Geriatrics Corporation
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,864,062 | Purified antigen for Alzheimer's disease and methods of obtaining and using same Lapsed on the fee record Ended Mar 8, 2013 · USPTO record | Lapsed on the fee record | Ended Mar 8, 2013 | USPTO record |
| US 7,173,132 | Certain substituted 1-aryl-3-piperazine-1′-yl propanones Lapsed on the fee record Ended Feb 6, 2011 · USPTO record | Lapsed on the fee record | Ended Feb 6, 2011 | USPTO record |
| US 6,306,857 | Methods for treating or preventing alzheimer's disease using substituted 1-aryl-3-piperazin-1'-yl propanones Lapsed on the fee record Ended Oct 23, 2009 · USPTO record | Lapsed on the fee record | Ended Oct 23, 2009 | USPTO record |
| US 6,214,994 | Certain substituted 1-aryl-3-piperazin-1'-yl propanones Lapsed on the fee record Ended Apr 10, 2009 · USPTO record | Lapsed on the fee record | Ended Apr 10, 2009 | USPTO record |
| US 6,228,878 | Methods for treating or preventing alzheimer's disease using substituted 2-aryl-3-morpholinopropanones Lapsed on the fee record Ended May 8, 2005 · USPTO record | Lapsed on the fee record | Ended May 8, 2005 | USPTO record |
| US 6,075,026 | Certain substituted 1-aryl-3-piperazin-1'-yl propanones Lapsed on the fee record Ended Jun 13, 2004 · USPTO record | Lapsed on the fee record | Ended Jun 13, 2004 | USPTO record |
| US 5,658,909 | Certain substituted 1-aryl-3-piperazin-1'-yl propanones to treat Alzheimer's Disease Term ended Term ended no later than Aug 19, 2017 · Low confidence | Term ended | Term ended no later than Aug 19, 2017 | Low confidence |
| US 5,693,804 | Substituted 1-aryl-3-piperazin-1'-yl propanones Term ended Term ended no later than Dec 2, 2017 · Low confidence | Term ended | Term ended no later than Dec 2, 2017 | Low confidence |
| US 5,705,501 | Certain substituted 1-aryl-3-morpholinopropanones to treat Alzheimer's Disease Term ended Term ended no later than Jan 6, 2018 · Low confidence | Term ended | Term ended no later than Jan 6, 2018 | Low confidence |
| US 5,968,936 | Methods for treating or preventing Alzheimer's Disease using substituted 1-aryl-3-morpholinopropanones Term ended Term ended no later than Oct 19, 2019 · Low confidence | Term ended | Term ended no later than Oct 19, 2019 | Low confidence |